Case File
efta-efta01039626DOJ Data Set 9OtherFrom: "jeffrey E." <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01039626
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "jeffrey E." <[email protected]>
To: Jeffrey Epstein <[email protected]>
Subject: Fwd: bitcoin - a new liquid market?
Date: Tue, 25 Jul 2017 14:18:18 +0000
Forwarded message
From: Morris, Paul V 4
Date: Mon, Jul 24, 2017 at 2:01 PM
Subject: RE: bitcoin - a new liquid market?
To: "jeevacation®gmail.com" [email protected]>
Bitcoin: a new liquid market?
Is bitcoin a currency? A commodity? Neither? A proper store of value like the EUR, T-bills, or gold is measured
by 3 factors: safety, liquidity, and return. Diversification is a plus. Bitcoin remains very volatile. But it has
experienced a surge in liquidity in the last six months, surpassing $2bn a day. Moreover, bitcoin is uncorrelated
to any financial asset, commodity, or currency we study in this note. The fiipside of extreme diversification is that
there is no way to explain let alone predict returns. Could bitcoin see a virtuous cycle of increased liquidity,
lower volatility, attractive returns, and wider acceptance? Possibly, if regulated financial institutions move to
allow bitcoin as pledgeable collateral. However, large inherent risks to digital tokens such as fraud, hacking,
theft, new protocol adoption, limited acceptance, and that it is not legal tender many places in the world make it
an unlikely development.
From: Morris, Paul V
Sent: Monday, July 24, 2017 1:51 PM
To:
<jeevacation®gmail.com>
Subject: bitcoin - a new liquid market?
Thought you would find interesting.
This message, and any attachments, is for the intended recipient(s) only, may contain information that is
privileged, confidential and/or proprietary and subject to important terms and conditions available at
http://www.bankofamerica.com/emaildisclaimer. If you are not the intended recipient, please delete this message.
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
EFTA01039626
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA01039627
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.